Protective Effects of Vildagliptin against Pioglitazone-Induced Bone Loss in Type 2 Diabetic Rats
Fare) (No. HI13C-1602-010015) and the Grant of Handok pharmaceutical company, Republic of Korea. Conceptualization: YSE ARG KMK SHY SL YSK IBP KWK KL BJK. Data...
Hier geht es zum ausführlichen Bericht